Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2018 · research · LRRK2 Biology Consortium
LRRK2 Inhibitors for the Treatment of Gastrointestinal Symptoms of Parkinson’s Disease
R. Jeremy Nichols · Stanford University
2018 · research · Research Grant
Studying Lipids in the Blood as Indicators of Pre-clinical and Early Parkinson’s Disease
Mikael Simons · Institute Of Neuronal Cell Biology (tum-ncb), Technical University Of Munich, German Center For Neur
2018 · research · Alpha-Synuclein Biology and Therapies
Antisense Oligonucleotides as Drug Candidates for Alpha-Synuclein-Linked Diseases
Epaminondas Doxakis · Academy of Athens
2018 · research · GBA Biology and Therapies
Sphingolipid and Alpha-synuclein Interactions
Kathryn Vanya Ewart · Dalhousie University
2018 · research · Research Grant
Conformational Changes in the Activation of the Ubiquitin Ligase Parkin
Kalle Gehring · McGill University
2018 · research · GBA Biology and Therapies
Role of GBA in Mitochondrial Antigen Presentation
Michel Desjardins · Université de Montréal
2018 · research · Research Grant
Genetic Factors that Influence Inherited Parkinson's Disease Associated with Changes in the GBA gene
Ziv Gan-Or · McGill University
2018 · research · Therapeutic Pipeline Program
Exosomal Delivery of shRNA Minicircles to Halt Neurodegeneration and Parkinson's
Lydia Alvarez-Erviti · Center For Biomedical Research Of La Rioja (cibir), Fundacion Rioja Salud
2018 · research · Target Advancement Program
Role of Neuromelanin in Parkinson's Disease and Brain Aging
Miquel Vila · Catalan Institution For Research And Advanced Studies, Vall D’hebron Research Institute
2018 · research · Research Grant
Does Mitochondrial Dysfunction in the Skin Predict That in the Brain?
Oliver Bandmann · University of Sheffield
2018 · research · Research Grant
Evaluation and Comparison of Existing Tests for Alpha-synuclein
Hilal A. Lashuel · École Polytechnique Fédérale de Lausanne
2018 · research · GBA Biology and Therapies
Impact of Genetic Variants in GBA on Parkinson’s Disease
Justin M. O'Sullivan · University of Auckland
2018 · research · Research Grant
Studying Structures of LRRK2 to Understand and Slow Parkinson's Disease
Susan S. Taylor · University of California San Diego
2018 · research · Research Grant
The Role of FcgRIIb in Alpha-synuclein Toxicity and Spread
Ali Roghanian · University of Southampton
2018 · research · Research Grant
Assessing the Effects of the Glucosylceramide Lipid on Protein Clumping
Joseph R. Mazzulli · Northwestern University
2018 · research · Research Grant
Discovery of Microbiome Biomarkers for Parkinson's Disease
Sarkis K. Mazmanian · California Institute of Technology
2018 · research · Research Grant
Measuring Protein Modifications to Monitor the Efficacy of LRRK2 Inhibitors
Adamantios Mamais · National Institute on Aging
2018 · research · Research Grant
Improving Existing LRRK2 Tests with Novel Reagents
Hardy J. Rideout · Biomedical Research Foundation of the Academy of Athens
2018 · research · Therapeutic Pipeline Program
Dual Leucine Zipper Kinase Inhibitors for Parkinson's Disease
Ronald A. Depinho · The University of Texas MD Anderson Cancer Center
2017 · research · Improved Biomarkers and Clinical Outcome Measures
Dopamine Buffering Capacity Measured by phMRI as a Novel Biomarker of Disease Progression in Parkinson's Disease
Kevin J. Black · Washington University in St. Louis
2017 · research · Research Grant
Standard Operating Procedures for Alpha-synuclein Analysis in Biological Fluids Using a Colorimetric Immunoassay (SYN-SOP)
Hugo Vanderstichele · ADx NeuroSciences
2017 · research · Research Grant
Stem Cells with Different Amounts of Alpha-synuclein as a Drug Discovery Tool
Birgitt Schüle · Stanford Medicine
2017 · research · Research Grant
Using Neural Cells to Test New Drugs that Activate PINK1 and Parkin
Steven Finkbeiner · University of California, San Francisco
2017 · research · Research Grant
Using Immune Cells to Treat Parkinson's Disease
Saar I. Gill · University of Pennsylvania
2017 · research · Research Grant
Making Changes in the Parkin Gene to Activate the Protein Parkin
Jean-François Trempe · McGill University
2017 · research · LRRK2 Biology Consortium
From Structure to Function: Targeting LRRK2-mediated Parkinson's Disease
Arjan Kortholt · University of Groningen
2017 · research · Research Grant
Developing Disease-modifying Chemical Probes to Inhibit Alpha-synuclein Accumulation
Pamela J. Mclean · Mayo Clinic in Florida
2017 · research · Computational Science
Complex Data Analysis for the Development of Parkinson’s Disease Biomarkers
Wasim Q. Malik · Massachusetts General Hospital
2017 · research · Therapeutic Pipeline Program
Small-Molecule Pharmacological Chaperones Reverse Alpha-synuclein-impaired Debris Removal
Lisa Claire Mcconlogue · University of California, San Francisco
2017 · research · Research Grant
Radioactive Molecules for Detection of Alpha-synuclein and Amyloid-beta in the Brain
Kenneth Marek · Institute for Neurodegenerative Disorders
2017 · research · Research Grant
A Proof-of-Concept Study of Mitochondrial Drugs in Pre-Clinical Models of Parkinson’s Disease
John Gerard Geisler · Mitochon Pharmaceuticals, Inc.
2017 · research · Therapeutic Pipeline Program
Protein Homeostasis and the Ubiquitination Pathway in Parkinson's Disease
Stephanos Ioannidis · Forma Therapeutics (United States)
2017 · research · Computational Science
Using Mathematical Tools to Explain the Variability in Parkinson’s Disease Symptoms and Progression
Caleb Webber · Cardiff University
2017 · research · Target Advancement Program
A Novel Role for Galectin Proteins in the Neuronal Response to Alpha-synuclein Invasion
Edward M. Campbell · Loyola University Chicago
2017 · research · Research Grant
White Blood Cell and Urine Collection in LRRK2 and GBA Mutation Carriers
Un Jung Kang · New York University
2017 · research · Research Grant
Blood Proteins for the Treatment of Parkinson’s Disease
Sam Jackson · Alkahest, Inc.
2017 · research · Target Advancement Program
Synapsin III as a Novel Therapeutic Target in Parkinson's Disease
Arianna Bellucci · University of Brescia
2017 · research · Therapeutic Pipeline Program
Pre-clinical Development of LBT-3627, a Potential Neuroprotective and Anti-inflammatory Therapy for Parkinson's Disease
Howard E. Gendelman · University of Nebraska Medical Center
2017 · research · Research Grant
Imaging Agents for Tauopathies and Alpha-Synuclein
Neil Vasdev · Centre for Addiction and Mental Health
2017 · research · Research Grant
Using Antibodies to Confirm Sticky Alpha-synuclein as the Cause of Parkinson's Disease
Glenda Margaret Halliday · The University of Sydney